ELFIA ALCALA: Open Payments
NPI 1457895211 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 26 payments from 10 companies in 2025. Trend: 2023 $235 · 2024 $227 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $159 |
| ABBVIE INC. | 6 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $84 |
| PFIZER INC. | 2 | $46 |
| Gilead Sciences, Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Dynavax Technologies Corporation | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Wegovy, TRINTELLIX, QULIPTA, NURTEC ODT, UBRELVY, LEQVIO, Kerendia, Heplisav-B.
Industry payments across FL — which companies pay providers there.
